Last update : 05/27/2014 | Version : 1 | ID : 8996
General | |
Identification | |
Detailed name | Case-control study on child psoriasis and overweight |
Sign or acronym | CHI-PSOCAR |
General Aspects | |
Medical area |
Endocrinology and metabolism |
Health determinants |
Nutrition |
Keywords | cardiovascular comordibity., Severity, overweight, obesity, metabolic |
Scientific investigator(s) (Contact) | |
Name of the director | Mahé |
Surname | Emmanuel |
Address | 69 Rue du Lieutenant Colonel Prudhon, 95107 Argenteuil, France |
emmanuel.mahe@ch-argenteuil.fr | |
Unit | Service de dermatologie |
Organization | Centre Hospitalier Victor Dupouy |
Collaborations | |
Funding | |
Funding status |
Public |
Details | CHU |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Centre Hospitalier Argenteuil |
Organisation status |
Public |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Case control study |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. |
All children (less than 18) affected by psoriasis seen in consultation or hospitalized for psoriasis (in one of the 23 centers with investigators members of the French Society of Pediatric Dermatology Research Group) were included. Control patients, children consulting for another reason than chronic or genetic inflammatory disease, were paired by age, sex and center. |
Database objective | |
Main objective | Cardiovascular and metabolic comorbidities are more frequent in psoriasis patients than in the general population. Limited data are available for children psoriasis. There seems to be a link between plaque psoriasis and obesity, even more marked when the child is affected by severe psoriasis. The main objective of this study is to assess the frequency of overweight (including obesity) in children affected by psoriasis, whatever the type of psoriasis. |
Inclusion criteria |
- age inferior or equal to 18 - psoriasis patients |
Population type | |
Age |
Early childhood (2 to 5 years) Childhood (6 to 13 years) Adolescence (13 to 18 years) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 04/2012 |
Date of last collection (YYYY or MM/YYYY) | 03/2013 |
Size of the database | |
Size of the database (number of individuals) |
[500-1000[ individuals |
Details of the number of individuals | 550 (275 case / 275 control patients). |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data |
Clinical data (detail) |
Direct physical measures Medical registration |
Details of collected clinical data | Psoriasis severity, child and parents' metabolic and cardiovascular comorbidities, overweight, obesity, body mass index. |
Details of collected declarative data | Psoriasis severity, child and parents' metabolic and cardiovascular comorbidities, overweight, obesity, body mass index. |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity |
Procedures | |
Participant monitoring |
No |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Via publications. For more information, contact the scientific investigator. |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05